234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)
234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)

CINCINNATI—Ischemic stroke patients aged 80 and over are more likely to qualify for the clot-busting drug rt-PA than the general population, new research from the University of Cincinnati Neuroscience Institute (UCNI) shows. Dawn Kleindorfer, MD, Associate Professor in UC’s Department of Neurology and a member of UCNI, is presenting the research Wednesday, Feb. 24, at the American Stroke Association’s International Stroke Conference 2010 in San Antonio. Read more >>
* * *
The UC Neuroscience Institute, a regional center of excellence, is dedicated to patient care, research, education, and the development of new treatments for stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, neuromuscular disorders, disorders of the senses (swallowing, voice, hearing, pain, taste and smell), and psychiatric conditions (bipolar disorder, schizophrenia, and depression).